These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26211665)

  • 1. Haptoglobin and CCR2 receptor expression in ovarian cancer cells that were exposed to ascitic fluid: exploring a new role of haptoglobin in the tumoral microenvironment.
    Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Gallardo-Rincón D; Talamás-Rohana P
    Cell Adh Migr; 2015; 9(5):394-405. PubMed ID: 26211665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The obesity and inflammatory marker haptoglobin attracts monocytes via interaction with chemokine (C-C motif) receptor 2 (CCR2).
    Maffei M; Funicello M; Vottari T; Gamucci O; Costa M; Lisi S; Viegi A; Ciampi O; Bardi G; Vitti P; Pinchera A; Santini F
    BMC Biol; 2009 Dec; 7():87. PubMed ID: 20017911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated protein C upregulates ovarian cancer cell migration and promotes unclottability of the cancer cell microenvironment.
    Althawadi H; Alfarsi H; Besbes S; Mirshahi S; Ducros E; Rafii A; Pocard M; Therwath A; Soria J; Mirshahi M
    Oncol Rep; 2015 Aug; 34(2):603-9. PubMed ID: 26082331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.
    Garibay-Cerdenares OL; Hernández-Ramírez VI; Osorio-Trujillo JC; Hernández-Ortíz M; Gallardo-Rincón D; Cantú de León D; Encarnación-Guevara S; Villegas-Pineda JC; Talamás-Rohana P
    J Ovarian Res; 2014 Feb; 7():27. PubMed ID: 24576319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCP-1 promotes invasion and adhesion of human ovarian cancer cells.
    Furukawa S; Soeda S; Kiko Y; Suzuki O; Hashimoto Y; Watanabe T; Nishiyama H; Tasaki K; Hojo H; Abe M; Fujimori K
    Anticancer Res; 2013 Nov; 33(11):4785-90. PubMed ID: 24222114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles derived from ascitic fluid enhance growth and migration of ovarian cancer cells.
    Mitra A; Yoshida-Court K; Solley TN; Mikkelson M; Yeung CLA; Nick A; Lu K; Klopp AH
    Sci Rep; 2021 Apr; 11(1):9149. PubMed ID: 33911091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial cancer cell migration: a role for chemokine receptors?
    Scotton CJ; Wilson JL; Milliken D; Stamp G; Balkwill FR
    Cancer Res; 2001 Jul; 61(13):4961-5. PubMed ID: 11431324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haptoglobin expression in endometrioid adenocarcinoma of the uterus.
    Nabli H; Tuller E; Sharpe-Timms KL
    Reprod Sci; 2010 Jan; 17(1):47-55. PubMed ID: 19801537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.
    Gericke B; Raila J; Sehouli J; Haebel S; Könsgen D; Mustea A; Schweigert FJ
    BMC Cancer; 2005 Oct; 5():133. PubMed ID: 16225703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi targeting of CCR2 gene expression induces apoptosis and inhibits the proliferation, migration, and invasion of PC-3M cells.
    Gao J; Wang A; Zhang M; Li H; Wang K; Han Y; Wang Z; Shi C; Wang W
    Oncol Res; 2013; 21(2):73-82. PubMed ID: 24406043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affino-immunoelectrophoresis of haptoglobin with wheat germ agglutinin. Diagnostic significance in ovarian carcinoma.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):547-52. PubMed ID: 3439855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
    Orellana R; Kato S; Erices R; Bravo ML; Gonzalez P; Oliva B; Cubillos S; Valdivia A; Ibañez C; Brañes J; Barriga MI; Bravo E; Alonso C; Bustamente E; Castellon E; Hidalgo P; Trigo C; Panes O; Pereira J; Mezzano D; Cuello MA; Owen GI
    BMC Cancer; 2015 Apr; 15():290. PubMed ID: 25886038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERS-based quantitative detection of ovarian cancer prognostic factor haptoglobin.
    Perumal J; Balasundaram G; Mahyuddin AP; Choolani M; Olivo M
    Int J Nanomedicine; 2015; 10():1831-40. PubMed ID: 25834423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A1 as a potential biomarker in the ascitic fluid for the differentiation of advanced ovarian cancers.
    Hariprasad G; Hariprasad R; Kumar L; Srinivasan A; Kola S; Kaushik A
    Biomarkers; 2013 Sep; 18(6):532-41. PubMed ID: 23902290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells.
    Ip CK; Cheung AN; Ngan HY; Wong AS
    Oncogene; 2011 May; 30(21):2420-32. PubMed ID: 21258406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
    Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals.
    Rao Q; Chen Y; Yeh CR; Ding J; Li L; Chang C; Yeh S
    Oncotarget; 2016 Feb; 7(7):7842-55. PubMed ID: 26556868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.